1.
Correction to: Outcomes of mothers and newborns to prenatal exposure to kratom: a systematic review.
J Perinatol
; 42(3): 420, 2022 Mar.
Article
in English
| MEDLINE
| ID: mdl-34584198
2.
J Perinatol
; 41(6): 1236-1243, 2021 06.
Article
in English
| MEDLINE
| ID: mdl-33589723
ABSTRACT
Kratom is a legal, widely available substance that contains opioid agonist alkaloids. Due to the marketing of kratom as an opioid alternative for treatment of pain, anxiety, depression, or to reduce opioid withdrawal symptoms, the use of kratom has increased among persons in the USA including pregnant women. This systematic review of the peer-reviewed literature regarding kratom in relation to maternal and infant outcomes resulted in analysis of six case reports of prenatal kratom exposure. Maternal and infant withdrawal from kratom exposure was described in each case, resulting in pharmacologic treatment for both mothers and infants.